Jafron Biomedical Co.,Ltd.

XSEC:300529 Stock Report

Market Cap: CN¥23.3b

Jafron BiomedicalLtd Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Fan Dong

Chief executive officer

CN¥3.7m

Total compensation

CEO salary percentagen/a
CEO tenure14.3yrs
CEO ownership45.9%
Management average tenure2yrs
Board average tenure3.5yrs

Recent management updates

Recent updates

CEO

Fan Dong (54 yo)

14.3yrs

Tenure

CN¥3,741,000

Compensation

Mr. Fan Dong serves as Chairman of Board of Directors and General Manager at Jafron Biomedical Co., Ltd. He serves as Director since April 27, 2023 at Jafron Biomedical Co.,Ltd. He served as Company Secret...

Leadership Team

NamePositionTenureCompensationOwnership
Fan Dong
Chairman of Board of Directors & GMno dataCN¥3.74m45.86%
CN¥ 10.7b
Xueyun Liao
Director & Financial Director1.7yrsCN¥500.50k0.019%
CN¥ 4.4m
De Zhi Li
Deputy General Managerno dataCN¥865.40k0.46%
CN¥ 106.4m
Xian Min Tang
Deputy GM & Directorno dataCN¥2.65m2.76%
CN¥ 641.4m
Aijun Wu
Deputy General Manager4.6yrsCN¥2.44m0.031%
CN¥ 7.3m
Rui Wang
General Manager1.3yrsCN¥510.40kno data
Cong Huang
Board Secretary2.3yrsCN¥455.20k0.00044%
CN¥ 102.4k

2.0yrs

Average Tenure

54yo

Average Age

Experienced Management: 300529's management team is not considered experienced ( 2 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Fan Dong
Chairman of Board of Directors & GM14.3yrsCN¥3.74m45.86%
CN¥ 10.7b
Xueyun Liao
Director & Financial Directorless than a yearCN¥500.50k0.019%
CN¥ 4.4m
Xian Min Tang
Deputy GM & Director14.3yrsCN¥2.65m2.76%
CN¥ 641.4m
Claudio Ronco
Member of Global Advisory Board3.5yrsno datano data
Feng Li
Non-Independent Director4.7yrsCN¥1.08m0.099%
CN¥ 23.0m
Xiaohong Peng
Chairman of Supervisory Board4.7yrsno datano data
Wen Lei
Non-Independent Director4.7yrsCN¥177.20kno data
Rinaldo Bellomo
Member of Global Advisory Board3.5yrsno datano data
Thomas Rimmelé
Member of Global Advisory Board3.5yrsno datano data
John Prowle
Member of Global Advisory Board3.5yrsno datano data
Antoine Schneider
Member of Global Advisory Board3.5yrsno datano data
Olivier Joannes-Boyau
Member of Global Advisory Board3.5yrsno datano data

3.5yrs

Average Tenure

54yo

Average Age

Experienced Board: 300529's board of directors are considered experienced (3.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 22:36
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jafron Biomedical Co.,Ltd. is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sophia ZhangChina Stock Investment Research Co. Ltd. (GZ500..com)
Shuo SongCitic Securities Co., Ltd.
Xiao Wei LinEverbright Securities Co. Ltd.